Andrew Shaughnessy

Is It Real Or Is It Memorex? Does AI Threaten IP?

Ask An IP Litigator: Do I Have A Great Patent? (Video)

Federal Court Of Appeal Underscores The Importance Of Patent Terms In Invalidating Claims To "Physiologically Acceptable" Salts

Federal Court Of Appeal Limits Scope Of Prohibition Against Patenting Methods Of Medical Treatment

Patent On Differin XP Gives PMPRB Pricing Jurisdiction Over Differin: Federal Court

Federal Court Of Appeal "Skinny Label" Case Highlights The Potential Power Of The Patentee

Interim Pricing Guidance Adopted As Canada's PMPRB Continues To Move Towards New Guidelines

FCA: PMPRB11 Stands For Patented Medicines

Four Life Sciences Regulatory And Litigation Trends And Their Practical Impact

Canada's PMPRB Guidelines Proposed For Stakeholder Consultation